GLP-1s: Second year cost of care is $4,200 higher for patients with obesity
Individuals without diabetes who newly started glucagon-like peptide-1 (GLP-1) agonist drugs for obesity experienced an average of $4,206...
top of page
Browse by category
Search
Costs of obesity management medications exceeds BMS in less than a year
The cost of taking weekly injections of popular obesity management medications liraglutide (Saxenda) or semaglutide (Wegovy) exceeds that...
Journal Watch 6/09/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Browse by tag
bottom of page